Cargando…
Future of newer basal insulin
Basal insulin have been developed over the years. In recent times newer analogues have been added to the armanentarium for diabetes therapy. This review specifically reviews the current status of different basal insulins
Autores principales: | Madhu, S. V., Velmurugan, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683199/ https://www.ncbi.nlm.nih.gov/pubmed/23776897 http://dx.doi.org/10.4103/2230-8210.109690 |
Ejemplares similares
-
New options for the medical treatment of Cushing's syndrome
por: Trainer, Peter J.
Publicado: (2013) -
Glucose‐stimulated insulin secretion: A newer perspective
por: Komatsu, Mitsuhisa, et al.
Publicado: (2013) -
Newer anabolic therapies in osteopororsis
por: Mittal, Monika, et al.
Publicado: (2012) -
Abstract 5: Similar hypoglycemia duration with once-weekly insulin icodec versus insulin glargine U100 in insulin naïve or experienced patients with T2D
por: Manjunath, Aparna, et al.
Publicado: (2022) -
Abstract 3: CGM-derived parameters for once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-Naïve patients with T2D
por: Kunder, Sushil, et al.
Publicado: (2022)